Addex to present at the swiss biotech day 2024

Geneva, switzerland, april 19, 2024 - addex therapeutics (six and nasdaq: adxn), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that ceo, tim dyer, will present at the swiss biotech day 2024 conference taking place april 22 - 23, 2024 at the congress center in basel, switzerland.

ADXN Ratings Summary

ADXN Quant Ranking